Bibliographic record

Semaglutide in patients with obesity-related heart failure and type 2 diabetes

Kosiborod MN, Petrie MC, Borlaug BA, Butler J, Davies MJ, Hovingh GK, Kitzman DW, Møller DV, Treppendahl MB, Verma S, Jensen TJ…. New England Journal of Medicine 2024

Document identifier: CEI-BR-062
Series: Bibliographic record
Version: 1.0
Published: 30 Jul 2026
Last reviewed: 30 Jul 2026
Certainty: Not rated

§1Bibliographic record

§1.1Record

Authors: Kosiborod MN, Petrie MC, Borlaug BA, Butler J, Davies MJ, Hovingh GK, Kitzman DW, Møller DV, Treppendahl MB, Verma S, Jensen TJ, Liisberg K, Lindegaard ML, Abhayaratna W, Ahmed FZ, Ben-Gal T, Chopra V, Ezekowitz JA, Fu M, Ito H
Title: Semaglutide in patients with obesity-related heart failure and type 2 diabetes
Source: New England Journal of Medicine
Year: 2024
Volume, issue, pages: 390(15):1394–1407
Digital object identifier: 10.1056/NEJMoa2313917
PubMed identifier: 38587233
Record type: Journal article
Institute identifier: CEI-BR-062

§1.2Institute documents citing this record

No Institute document currently cites this record. It is held in the bibliography because it was retrieved during a search and assessed, and the Institute records what it assessed and did not use as well as what it used.

§1.3Subject tags

semaglutide hfpef t2dm

Compound Evidence Institute · CEI-BR-062 · https://compoundevidence.com/bibliography/kosiborod2024/ · retrieved 30 July 2026